A detailed history of Fieldpoint Private Securities, LLC transactions in Incyte Corp stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 15 shares of INCY stock, worth $1,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 40 62.5%
Holding current value
$1,075
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$66.18 - $83.18 $1,654 - $2,079
-25 Reduced 62.5%
15 $1,000
Q1 2022

Apr 07, 2022

BUY
$66.02 - $79.71 $2,640 - $3,188
40 New
40 $3,000
Q1 2021

Apr 23, 2021

SELL
$76.02 - $100.5 $0 - $0
0 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$80.74 - $97.7 $0 - $0
0 New
0 $0
Q1 2018

May 08, 2018

SELL
$83.06 - $100.98 $28,655 - $34,838
-345 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$109.15 - $138.27 $37,656 - $47,703
345
345 $40,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.